Westfuller Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$149K Buy
5,231
+25
+0.5% +$665 0.04% 202
2026
Q2
$125K Buy
5,206
+4,402
+548% +$115K 0.05% 201
2026
Q1
$22.6K Buy
804
+104
+15% +$2.77K 0.01% 343
2025
Q4
$17.4K Buy
700
+35
+5% +$883 0.01% 388
2025
Q3
$16.9K Buy
+665
New +$16.4K 0.01% 392

Other funds holding PFE

Westfuller Advisors's PFE Position: Q3 2026 in Review

Westfuller Advisors increased its Pfizer (PFE) stake by 0.48% in Q3 2026, buying an estimated $665 and bringing the position to 5,231 shares worth $149K. The position accounts for 0.04% of the portfolio, ranked #202.

Westfuller Advisors first reported a position in PFE in Q3 2025 and has held it in 5 quarters since. 2,712 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Westfuller Advisors held 5,231 shares of Pfizer worth $149K as of Q3 2026.
  • Westfuller Advisors bought 25 Pfizer shares in Q3 2026, an estimated $665.
  • Pfizer made up 0.04% of Westfuller Advisors's portfolio in Q3 2026, its #202 holding.
  • Westfuller Advisors first reported a position in Pfizer in Q3 2025 and has held it in 5 quarters since.
  • 2,712 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Westfuller Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.